EB

Enzo Bartoli

Active Director Director DIN 02981898
DIN 02981898 First appointment Jan 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2012
Shareholding value •••• Premium profile

About Enzo Bartoli

Data last updated:

Enzo Bartoli is a Director at Raichem Medicare Private Limited (since 2012). The company operates in Pharma. Raichem Medicare Private Limited reported revenue of ₹515 Cr (FY 2025).

DIN 02981898
Primary Designation Director
Industry Pharma
First Appointment 30 Jan 2012
Oldest Company Age 17 yrs
Largest company Raichem Medicare Private Limited · ₹515 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Raichem Medicare Private Limited U24232KA2009PTC049999
Director30 Jan 20122009₹515 Cr (FY 2025)Active

Board colleagues of Enzo Bartoli

NameDINCompanyDesignation
Agostino Barazza08830494Raichem Medicare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Raichem Medicare Private Limited
Premium access

Shareholding and investment profile for Enzo Bartoli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Enzo Bartoli

Enzo Bartoli currently holds 1 directorship: Raichem Medicare Private Limited (Director, since 30 Jan 2012, revenue ₹515 Cr (FY 2025)).

Enzo Bartoli was first appointed on 30 Jan 2012 as Director at Raichem Medicare Private Limited.

The current boards of Enzo Bartoli's companies include Agostino Barazza (Raichem Medicare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available